News Conference News TCT 2025 ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR Todd Neale October 27, 2025
News Conference News TCT 2025 Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC Yael L. Maxwell October 27, 2025
News Conference News TCT 2025 PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States Caitlin E. Cox October 27, 2025
News Conference News TCT 2025 PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI Michael O'Riordan October 27, 2025
News Conference News TCT 2025 More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain Yael L. Maxwell October 26, 2025
News Conference News TCT 2025 TTVR Remains Safe, Effective in Presence of CIED Leads Todd Neale October 25, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Conference News TCT 2024 Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis Caitlin E. Cox November 08, 2024
News Conference News TCT 2024 Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick Yael L. Maxwell November 07, 2024
News Conference News TCT 2024 Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI Michael O'Riordan November 06, 2024
News Conference News TCT 2024 Pooled All-Female Analysis Support Benefits of TAVI Over SAVR L.A. McKeown November 01, 2024
News Conference News TCT 2024 Embolic Protection Benefits Varied by Geography in PROTECTED TAVR Todd Neale October 31, 2024
News Conference News TCT 2024 TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation Michael O'Riordan October 30, 2024
News Conference News TCT 2024 ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients Todd Neale October 30, 2024
Presentation TCT 2024 ACURATE IDE Insights: Optimizing Clinical Implants Presenter: NULL October 30, 2024
Presentation TCT 2024 Patient-Reported Outcomes are a True Measure of TTVI Value Presenter: John Spertus October 30, 2024
Presentation TCT 2024 CV Event Reduction is the Essential Criterion for Implementing New Device Therapies Presenter: Ori Ben-Yehuda October 30, 2024
Presentation TCT 2024 TCT 651: Clinical Presentation Before Aortic Valve Replacement for Aortic Stenosis Presenter: Philippe Genereux October 30, 2024
Presentation TCT 2024 TCT 653: Transcatheter or Surgical Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis Presenter: Philippe Genereux October 30, 2024
Presentation TCT 2024 Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials Presenter: Mahesh Madhavan October 30, 2024